Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial
- PMID: 23773313
- DOI: 10.1016/j.fertnstert.2013.04.039
Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial
Abstract
Objective: To determine if cleavage- or blastocyst-stage embryo biopsy affects reproductive competence.
Design: Paired randomized clinical trial.
Setting: Academic-assisted reproduction program.
Patient(s): Attempting conception through IVF.
Intervention(s): After selecting two embryos for transfer, one was randomized to biopsy and the other to control. Both were transferred within shortly thereafter. The biopsy was submitted for microarray analysis and single-nucleotide polymorphism (SNP) profiling. Buccal DNA obtained from the neonate after delivery had microarray analysis and SNP profile compared with that of the embryonic DNA. A match confirmed that the biopsied embryo implanted and developed to term, whereas a nonmatch indicated that the control embryo had led to the delivery.
Main outcome measure(s): Paired analysis of the delivery rates of the transferred embryos. Either twin delivery or failure to deliver represents equivalent outcomes for the biopsied and control embryos. In contrast, singletons were determined to be from the biopsied or the control embryo.
Result(s): Blastomere biopsy on day 3 of development resulted in a significant reduction in sustained implantation. Only 30% of biopsied embryos had sustained implantation and ultimately developed into live-born infants versus 50% of unbiopsied controls, a relative reduction of 39%. In contrast, sustained implantation rates were equivalent (51% vs. 54%) for biopsied and control blastocysts.
Conclusion(s): Cleavage-stage biopsy markedly reduced embryonic reproductive potential. In contrast, trophectoderm biopsy had no measurable impact and may be used safely when embryo biopsy is indicated.
Clinical trial registration number: NCT01219504.
Keywords: DNA fingerprinting; Embryo biopsy; IVF; preimplantation genetic diagnosis.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial.Fertil Steril. 2013 Sep;100(3):697-703. doi: 10.1016/j.fertnstert.2013.04.035. Epub 2013 Jun 1. Fertil Steril. 2013. PMID: 23731996 Clinical Trial.
-
Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts.Fertil Steril. 2005 Dec;84(6):1628-36. doi: 10.1016/j.fertnstert.2005.05.063. Fertil Steril. 2005. PMID: 16359956
-
Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts.Hum Reprod. 2014 Jun;29(6):1173-81. doi: 10.1093/humrep/deu033. Epub 2014 Feb 26. Hum Reprod. 2014. PMID: 24578475 Clinical Trial.
-
Selecting the optimal time to perform biopsy for preimplantation genetic testing.Fertil Steril. 2013 Sep;100(3):608-14. doi: 10.1016/j.fertnstert.2013.07.004. Fertil Steril. 2013. PMID: 23993663 Review.
-
The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis.Biomed Res Int. 2016;2016:7193075. doi: 10.1155/2016/7193075. Epub 2016 Jan 28. Biomed Res Int. 2016. PMID: 26942198 Free PMC article. Review.
Cited by 89 articles
-
Trophectoderm biopsy for preimplantation genetic test and technical tips: A review.Reprod Med Biol. 2020 Jan 26;19(3):222-231. doi: 10.1002/rmb2.12318. eCollection 2020 Jul. Reprod Med Biol. 2020. PMID: 32684821 Free PMC article. Review.
-
Preimplantation Genetic Testing: Where We Are Today.Int J Mol Sci. 2020 Jun 19;21(12):4381. doi: 10.3390/ijms21124381. Int J Mol Sci. 2020. PMID: 32575575 Free PMC article. Review.
-
Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements.Genes (Basel). 2020 May 29;11(6):602. doi: 10.3390/genes11060602. Genes (Basel). 2020. PMID: 32485954 Free PMC article. Review.
-
IUI and uterine lavage of in vivo-produced blastocysts for PGT purposes: is it a technically and ethically reasonable perspective? Is it actually needed?J Assist Reprod Genet. 2020 Jul;37(7):1579-1582. doi: 10.1007/s10815-020-01813-7. Epub 2020 May 26. J Assist Reprod Genet. 2020. PMID: 32458102
-
Blastocysts Derived From 0PN Oocytes: Genetic And Clinical Results.JBRA Assist Reprod. 2020 May 1;24(2):143-146. doi: 10.5935/1518-0557.20190084. JBRA Assist Reprod. 2020. PMID: 32202747 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical